Financhill
Sell
37

BCH Quote, Financials, Valuation and Earnings

Last price:
$28.43
Seasonality move :
2.68%
Day range:
$28.11 - $28.52
52-week range:
$22.06 - $31.84
Dividend yield:
7.3%
P/E ratio:
10.62x
P/S ratio:
4.47x
P/B ratio:
2.44x
Volume:
382.8K
Avg. volume:
283.8K
1-year change:
19.39%
Market cap:
$14.4B
Revenue:
$3.2B
EPS (TTM):
$2.68
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Revenue $2.4B $2.9B $3.6B $3.5B $3.2B
Revenue Growth (YoY) -14.02% 20.01% 22.3% -0.91% -8.94%
 
Cost of Revenues -- -- -- -- --
Gross Profit -- -- -- -- --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $945M $917.3M $1.2B $1.4B $1.3B
Other Inc / (Exp) -$30.1M $460.9M -$120.9M $106.8M $136.9M
Operating Expenses $1B $1B $1.3B $1.5B $1.3B
Operating Income -- -- -- -- --
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items $639.4M $1.8B $2B $2B $1.7B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $130.7M $365M $333M $385M $354.7M
Net Income to Company $508.7M $1.4B $1.7B $1.6B $1.3B
 
Minority Interest in Earnings -$1.3K -$1.3K -$2.3K -$1.2K --
Net Income to Common Excl Extra Items $508.7M $1.4B $1.7B $1.6B $1.3B
 
Basic EPS (Cont. Ops) $1.01 $2.77 $3.30 $3.25 $2.63
Diluted EPS (Cont. Ops) $1.01 $2.77 $3.30 $3.25 $2.63
Weighted Average Basic Share $505.1M $505.1M $505.1M $505.1M $505.1M
Weighted Average Diluted Share $505.1M $505.1M $505.1M $505.1M $505.1M
 
EBITDA -- -- -- -- --
EBIT $1.3B $2.8B $4.5B $4.6B $3.4B
 
Revenue (Reported) $2.4B $2.9B $3.6B $3.5B $3.2B
Operating Income (Reported) -- -- -- -- --
Operating Income (Adjusted) $1.3B $2.8B $4.5B $4.6B $3.4B
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Revenue $657.6M $842.7M $867.6M $827.3M $808.8M
Revenue Growth (YoY) 3.66% 28.15% 2.95% -4.64% -2.23%
 
Cost of Revenues -- -- -- -- --
Gross Profit -- -- -- -- --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $259.1M $246M $287.9M $248.1M $242M
Other Inc / (Exp) $136.7M $302.1M $272.6M $191M $70.3M
Operating Expenses $287.7M $268.3M $306.8M $263.3M $258.9M
Operating Income -- -- -- -- --
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items $280.3M $435.2M $411.7M $406.9M $425.1M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $56.1M $73.9M $83.4M $90.9M $82.3M
Net Income to Company $224.2M $361.3M $328.3M $316M $342.7M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $224.2M $361.3M $328.3M $316M $342.7M
 
Basic EPS (Cont. Ops) $0.44 $0.72 $0.65 $0.63 $0.68
Diluted EPS (Cont. Ops) $0.44 $0.72 $0.65 $0.63 $0.68
Weighted Average Basic Share $505.1M $505.1M $505.1M $505.1M $505.1M
Weighted Average Diluted Share $505.1M $505.1M $505.1M $505.1M $505.1M
 
EBITDA -- -- -- -- --
EBIT $361.6M $612.7M $911.9M $765M $670.4M
 
Revenue (Reported) $657.6M $842.7M $867.6M $827.3M $808.8M
Operating Income (Reported) -- -- -- -- --
Operating Income (Adjusted) $361.6M $612.7M $911.9M $765M $670.4M
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Revenue $2.5B $3.1B $3.6B $3.5B $3.2B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues -- -- -- -- --
Gross Profit -- -- -- -- --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $975.4M $933.6M $1.2B $1.4B $1.3B
Other Inc / (Exp) $56.4M $642.7M -$81.5M $9.9M $81.6M
Operating Expenses $1.1B $1B $1.3B $1.5B $1.4B
Operating Income -- -- -- -- --
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items $704.1M $1.9B $2B $2B $1.7B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $145.4M $370.9M $340.7M $392.3M $345.8M
Net Income to Company $561.8M $1.5B $1.6B $1.6B $1.4B
 
Minority Interest in Earnings -$1.3K -$1.3K -$2.2K -$1.1K --
Net Income to Common Excl Extra Items $558.7M $1.5B $1.6B $1.6B $1.4B
 
Basic EPS (Cont. Ops) $1.11 $2.95 $3.22 $3.20 $2.68
Diluted EPS (Cont. Ops) $1.11 $2.95 $3.22 $3.20 $2.68
Weighted Average Basic Share
Weighted Average Diluted Share
 
EBITDA -- -- -- -- --
EBIT $1.2B $3B $4.7B $4.4B $3.3B
 
Revenue (Reported) $2.5B $3.1B $3.6B $3.5B $3.2B
Operating Income (Reported) -- -- -- -- --
Operating Income (Adjusted) $1.2B $3B $4.7B $4.4B $3.3B
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Revenue $657.6M $842.7M $867.6M $827.3M $808.8M
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues -- -- -- -- --
Gross Profit -- -- -- -- --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $259.1M $246M $287.9M $248.1M $242M
Other Inc / (Exp) $136.7M $302.1M $272.6M $191M $70.3M
Operating Expenses $287.7M $268.3M $306.8M $263.3M $258.9M
Operating Income -- -- -- -- --
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items $280.3M $435.2M $411.7M $406.9M $425.1M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $56.1M $73.9M $83.4M $90.9M $82.3M
Net Income to Company $224.2M $361.3M $328.3M $316M $342.7M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $224.2M $361.3M $328.3M $316M $342.7M
 
Basic EPS (Cont. Ops) $0.44 $0.72 $0.65 $0.63 $0.68
Diluted EPS (Cont. Ops) $0.44 $0.72 $0.65 $0.63 $0.68
Weighted Average Basic Share $505.1M $505.1M $505.1M $505.1M $505.1M
Weighted Average Diluted Share $505.1M $505.1M $505.1M $505.1M $505.1M
 
EBITDA -- -- -- -- --
EBIT $361.6M $612.7M $911.9M $765M $670.4M
 
Revenue (Reported) $657.6M $842.7M $867.6M $827.3M $808.8M
Operating Income (Reported) -- -- -- -- --
Operating Income (Adjusted) $361.6M $612.7M $911.9M $765M $670.4M
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Cash and Equivalents $4.2B $4.7B $4.2B $5.7B $3.1B
Short Term Investments $1.5B $3.6B $4.7B $2.1B $2.1B
Accounts Receivable, Net -- $112.2M $155.2M $114M $196.7M
Inventory -- -- -- -- --
Prepaid Expenses $41.7M $53.7M $46.9M $77.8M $54M
Other Current Assets -- -- -- -- --
Total Current Assets $11.8B $14.1B $15.2B $13.5B $10.8B
 
Property Plant And Equipment $593.9M $489.5M $471.6M $537.4M $451.7M
Long-Term Investments $8.1B $9.2B $10.2B $6.1B $5.1B
Goodwill $23.5M $19.6M $19.7M $19.2M $16.8M
Other Intangibles $108.8M $104.8M $145.4M $176.5M $176.5M
Other Long-Term Assets -- -- -- -- --
Total Assets $64B $60.4B $65B $63.9B $52.4B
 
Accounts Payable $384M $378.3M $447.5M $386.5M $423.2M
Accrued Expenses -- -- -- -- --
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations -- -- -- $26.6M $26.2M
Other Current Liabilities -- -- -- -- --
Total Current Liabilities $798.8M $732.7M $873.2M $907.8M $772.3M
 
Long-Term Debt $12.9B $10.7B $12.2B $13.1B $11.9B
Capital Leases -- -- -- -- --
Total Liabilities $58.4B $54.7B $58.6B $56.9B $45.9B
 
Common Stock $3.4B $2.8B $2.9B $2.8B $2.4B
Other Common Equity Adj $1.1B $831M $801.6M $986.1M $987.4M
Common Equity $5.6B $5.7B $6.4B $7B $6.6B
Total Preferred Equity -- -- -- -- --
Minority Interest, Total $1.4K $1.2K $2.4K $2.3K $2K
Total Equity $5.6B $5.7B $6.4B $7B $6.6B
 
Total Liabilities and Equity $64B $60.4B $65B $63.9B $52.4B
Cash and Short Terms $5.7B $8.3B $8.9B $7.8B $5.2B
Total Debt $12.9B $10.7B $12.2B $13.1B $11.9B
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Cash and Equivalents $4B $6.7B $4.3B $3.7B $4.1B
Short Term Investments $1.5B $3.4B $6.4B $3.3B $2.1B
Accounts Receivable, Net $1.7M $166M $268.9M $169.3M $305.6M
Inventory -- -- -- -- --
Prepaid Expenses $85.4M $69M $64.2M $82.5M $62.9M
Other Current Assets -- -- -- -- --
Total Current Assets $10.6B $13.9B $15.3B $12.8B $12.1B
 
Property Plant And Equipment $578.2M $479.6M $512.1M $441.8M $452.9M
Long-Term Investments $4.7B $5.2B $11B $9.8B $6.4B
Goodwill -- -- -- -- --
Other Intangibles $85.8M $92.1M $139.7M $149.3M $177.2M
Other Long-Term Assets -- -- -- -- --
Total Assets $61.7B $63.4B $69.7B $58.8B $58.7B
 
Accounts Payable $310.8M $442.7M $409.4M $436.5M $545.9M
Accrued Expenses -- -- -- -- --
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations -- -- -- -- $29M
Other Current Liabilities -- -- -- -- --
Total Current Liabilities $485.4M $993.5M $886.8M $879.3M $1B
 
Long-Term Debt $13.1B $11.1B $13.3B $11.4B $13.5B
Capital Leases -- -- -- -- --
Total Liabilities $56.5B $58.1B $63.7B $53.4B $52.8B
 
Common Stock $3.3B $3.1B $3.1B $2.5B $2.6B
Other Common Equity Adj $800.3M $734.3M $716.7M $598.2M $605.6M
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total $1.4K $1.3K $2.5K $1K $2.2K
Total Equity $5.2B $5.3B $6B $5.4B $5.9B
 
Total Liabilities and Equity $61.7B $63.4B $69.7B $58.8B $58.7B
Cash and Short Terms $5.4B $10.2B $10.7B $7.1B $6.2B
Total Debt $13.1B $11.1B $13.3B $11.4B $13.5B
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Net Income to Stockholders $508.7M $1.4B $1.7B $1.6B $1.3B
Depreciation & Amoritzation $92.9M $101.6M $97M $110.3M $100.6M
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -$2.3B $1.9B -$737.7M -$406.8M $2B
Change in Inventories -- -- -- -- --
Cash From Operations -$3.1B $4B $148.1M $2.1B $3.9B
 
Capital Expenditures $60.7M $87M $90M $103.6M $79.6M
Cash Acquisitions -- -$10.4M -- -- $12.5M
Cash From Investing $266.4M -$4B -$976.1M -$414.2M $2.2B
 
Dividends Paid (Ex Special Dividend) -$444M -$291.3M -$621.5M -$1B -$867.7M
Special Dividend Paid
Long-Term Debt Issued $1.1B $2.2B $2.2B $1.5B $1.2B
Long-Term Debt Repaid -$2.8B -$1.8B -$1.8B -$2.2B -$1.6B
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities $66.7M $49.9M $108.4M -$56.3M -$58.3M
Cash From Financing $1.9B $1.8B -$186.3M -$1.9B -$6B
 
Beginning Cash (CF) $3.9B $3B $4.6B $3.8B $3.2B
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$1B $1.8B -$1B -$211.2M $115.7M
Ending Cash (CF) $2.9B $5.3B $3.6B $3.6B $3.5B
 
Levered Free Cash Flow -$3.2B $3.9B $58.1M $2B $3.8B
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Net Income to Stockholders $224.2M $361.3M $328.3M $316M $342.7M
Depreciation & Amoritzation $25.8M $24.7M $28.1M $24.8M $24.6M
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -$2.2B -$1.8B $712.9M $1.4B -$1.1B
Change in Inventories -- -- -- -- --
Cash From Operations -$3.2B -$1.7B -$580.2M -$91.9M $1.4B
 
Capital Expenditures $25.3M $11.8M $20.7M $21.4M $19.2M
Cash Acquisitions -- -- -- -- --
Cash From Investing -$24.9M -$11.8M -$20.7M -$21.1M -$16.3M
 
Dividends Paid (Ex Special Dividend) -$304.9M -$668.6M -$1.1B -$866.1M -$1B
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $575.1M $306.3M $299M $334.2M $388.9M
Long-Term Debt Repaid -$205.9M -$466.3M -$242M -$292.1M -$191.3M
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash From Financing $64.4M -$828.6M -$1B -$824M -$839.5M
 
Beginning Cash (CF) $8.4B $9B $7.5B $5.9B $4.7B
Foreign Exchange Rate Adjustment $19.8M -$267.5M -$148.3M $197.2M -$39.5M
Additions / Reductions -$3.1B -$2.5B -$1.6B -$937M $501.4M
Ending Cash (CF) $5.3B $6.2B $5.8B $5.1B $5.1B
 
Levered Free Cash Flow -$3.2B -$1.7B -$600.9M -$113.3M $1.3B
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Net Income to Stockholders $561.8M $1.5B $1.6B $1.6B $1.4B
Depreciation & Amoritzation $95.6M $100.5M $100.4M $107.1M $100.4M
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -- $2.3B $1.8B $263M -$485.1M
Change in Inventories -- -- -- -- --
Cash From Operations -$6.6B $5.5B $1.2B $2.6B $5.4B
 
Capital Expenditures $65.2M $73.6M $98.8M $104.4M $77.3M
Cash Acquisitions -- -$10.4M -- -- $12.5M
Cash From Investing $625.4M -$3.9B -$985M -$414.6M $2.2B
 
Dividends Paid (Ex Special Dividend) -$311M -$655.1M -$1B -$832.2M -$1B
Special Dividend Paid
Long-Term Debt Issued $949.1M $1.9B $2.2B $1.5B $1.2B
Long-Term Debt Repaid -$2.6B -$2B -$1.6B -$2.3B -$1.5B
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash From Financing $2.1B $927.2M -$370.9M -$1.7B -$6B
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$3.9B $2.5B -$106.1M $465.8M $1.6B
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow -$6.7B $5.4B $1.2B $2.4B $5.3B
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Net Income to Stockholders $224.2M $361.3M $328.3M $316M $342.7M
Depreciation & Amoritzation $25.8M $24.7M $28.1M $24.8M $24.6M
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -$2.2B -$1.8B $712.9M $1.4B -$1.1B
Change in Inventories -- -- -- -- --
Cash From Operations -$3.2B -$1.7B -$580.2M -$91.9M $1.4B
 
Capital Expenditures $25.3M $11.8M $20.7M $21.4M $19.2M
Cash Acquisitions -- -- -- -- --
Cash From Investing -$24.9M -$11.8M -$20.7M -$21.1M -$16.3M
 
Dividends Paid (Ex Special Dividend) -$304.9M -$668.6M -$1.1B -$866.1M -$1B
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $575.1M $306.3M $299M $334.2M $388.9M
Long-Term Debt Repaid -$205.9M -$466.3M -$242M -$292.1M -$191.3M
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash From Financing $64.4M -$828.6M -$1B -$824M -$839.5M
 
Beginning Cash (CF) $8.4B $9B $7.5B $5.9B $4.7B
Foreign Exchange Rate Adjustment $19.8M -$267.5M -$148.3M $197.2M -$39.5M
Additions / Reductions -$3.1B -$2.5B -$1.6B -$937M $501.4M
Ending Cash (CF) $5.3B $6.2B $5.8B $5.1B $5.1B
 
Levered Free Cash Flow -$3.2B -$1.7B -$600.9M -$113.3M $1.3B

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Will GoodRX Stock Bounce Back?
Will GoodRX Stock Bounce Back?

GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…

Will FCX Benefit From Tariffs?
Will FCX Benefit From Tariffs?

Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…

Can Levi Stock Double?
Can Levi Stock Double?

Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…

Stock Ideas

Buy
71
Is NVDA Stock a Buy?

Market Cap: $4.2T
P/E Ratio: 59x

Buy
51
Is MSFT Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 43x

Sell
40
Is AAPL Stock a Buy?

Market Cap: $3.1T
P/E Ratio: 35x

Alerts

Buy
68
MCRI alert for Jul 18

Monarch Casino & Resort [MCRI] is up 19.81% over the past day.

Sell
41
NEGG alert for Jul 18

Newegg Commerce [NEGG] is up 17.85% over the past day.

Buy
72
MNPR alert for Jul 18

Monopar Therapeutics [MNPR] is up 13.2% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock